Triumph Bancorp Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock
DALLAS, Aug. 31, 2020 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (the “Company”) (Nasdaq: TBK) today announced the Company’s Board of […]
Varonis to Present at September Investor Conferences
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a pioneer in data security and analytics, […]
Pandion Reports Second Quarter 2020 Financial Results and Provides Business Update
– Completed successful IPO providing approximately $153 million in gross proceeds; cash runway extended through first half of 2024– Expanded […]
T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
LEXINGTON, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]
Zosano Pharma Announces Proposed Public Offering of Common Stock
FREMONT, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has […]
Brickell Biotech Announces Issuance of New Composition of Matter Patent on Sofpironium Bromide by the Japanese Patent Office
Claims directed to novel crystalline forms of sofpironium bromidePatent protection in Japan granted through 2040BOULDER, Colo., Aug. 31, 2020 (GLOBE […]
Opiant Pharmaceuticals to Participate at the 2020 Cantor Global Virtual Healthcare Conference
SANTA MONICA, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines […]
SiTime Raises Revenue Guidance for the Third Quarter of 2020
SANTA CLARA, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) — SiTime Corporation, (Nasdaq: SITM), a market leader in MEMS timing, today […]
UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer
SAN FRANCISCO, Aug. 31, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan […]
Cue Biopharma Reports Second Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
CAMBRIDGE, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel […]
